Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04167748 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Preimplantation Genetic Testing in Women of Advanced Maternal Age

Study acronym: GETSET
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated August 26, 2025 (before its estimated November 1, 2025 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion date: Nov 1, 2024 to Nov 1, 2025
    • Study completion date: Dec 2024 to Dec 2026
    • Site contact updated
    v18
  2. Primary completion date: Nov 1, 2023 to Nov 1, 2024v17
  3. Site contact updatedv16
  4. Primary completion date: Nov 1, 2022 to Nov 1, 2023v15
  5. Start date changed from estimate of Feb 1, 2021 to Mar 5, 2021v14
Show 12 earlier versionsHide 12 earlier versions
  1. Start date: Nov 1, 2020 to Feb 1, 2021v13
  2. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 1
    v12
  3. Re-verified, no change to tracked fieldsv11
  4. Study title expanded, about 3 wordsv10
  5. Lead sponsor: Stanford University to Genomic Prediction Inc.v9 Show 9 more changesShow less
    • Trial status: Withdrawn to Not Yet Recruiting
    • Start date: Jun 2020 to Nov 1, 2020
    • Primary endpoint revised
    • Enrollment target: 0 to 240
    • Primary completion date: Jun 2023 to Nov 1, 2022
    • Study completion date: Jun 2024 to Dec 2024
    • Eligibility criteria expanded, about 16 words
    • Study description shortened, about 187 words
    • Study title shortened, about 7 words
  6. Trial status: Not Yet Recruiting to Withdrawn Sponsor's reason: Per discretion of principal investigator
    • Enrollment target: estimated 200 to confirmed 0
    v8
  7. Collaborators shortened, about 5 wordsv7
  8. Start date: Jan 2020 to Jun 2020v6 Show 4 more changesShow less
    • Primary completion date: Jan 2023 to Jun 2023
    • Study completion date: Jan 2024 to Jun 2024
    • Study description shortened, about 10 words
    • Collaborators: 2 to 1
  9. Study description revisedv5
  10. Collaborators revised (2)v4
  11. Study description expanded, about 10 words
    • Collaborators: 1 to 2
    v3
  12. Study description expanded, about 1 wordv2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The GETSET trial is a prospective randomized trial designed to evaluate the clinical outcomes of incorporating preimplantation genetic testing for aneuploidies (PGT-A) in elective single embryo transfer in women between 35 and 40 years of age.
Trial Details
NCT Number NCT04167748
Lead Sponsor Genomic Prediction Inc.
Conditions
(from sponsor)		 Infertility, Female
Related terms Infertility, Female
Enrollment 240 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov